600976.SH
健民集团
SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
CNY 27.58
+0.15%Sep 3, 2026, 10:29 UTC
Jianmin Group announced that its Crisaborole Ointment received approval from China's National Medical Products Administration and was launched on the market.
Source:Aug 19, 2026, 08:44 UTC
Jianmin Group announced its 2026 half-year results: revenue of 1.611 billion yuan, down 10.72% year-on-year; net profit attributable to shareholders of 177 million yuan, down 19.68% year-on-year.